Bonita David P 4

What Happened Bonita David, a director of ImageneBio (IMA), received a grant of 15,600 shares (derivative award) on 2026-06-16. The award shows an acquisition price of $0.00 in the Form 4, meaning no cash was paid at grant; the shares are subject to vesting conditions under the company's 2025 Equity Incentive Plan. This is an equity award (code A) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-16; Filing date (Form 4): 2026-06-18 (filed within the standard 2-business-day window).
• Security and amount: 15,600 shares granted; reported acquisition price $0.00.
• Shares owned after transaction: not specified in the filing.
• Vesting: Per footnote F1 — the shares vest in full upon the earlier of (a) the first anniversary of the grant date, (b) the issuer’s next annual meeting, or (c) a change of control as defined in the 2025 Equity Incentive Plan.
• Transaction type: Award/grant of restricted/derivative shares (code A).

Context Director awards are a common form of compensation and do not necessarily signal immediate buying or selling intent. Because these are time- or event-based vesting awards (including change-of-control acceleration), they reflect long-term compensation rather than an immediate market move.